Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Tax Provisions (2022 - 2025)

bioAffinity Technologies has reported Tax Provisions over the past 4 years, most recently at $3181.0 for Q4 2025.

  • Quarterly Tax Provisions changed N/A to $3181.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44042.0 through Dec 2025, up 278.04% year-over-year, with the annual reading at $44042.0 for FY2025, 278.04% up from the prior year.
  • Tax Provisions was $3181.0 for Q4 2025 at bioAffinity Technologies, roughly flat from $3182.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $28984.0 in Q2 2025 and troughed at -$1.0 in Q4 2022.
  • The 4-year median for Tax Provisions is $3181.5 (2025), against an average of $5653.1.
  • Year-over-year, Tax Provisions surged 229400.0% in 2023 and then plummeted 68.93% in 2024.
  • A 4-year view of Tax Provisions shows it stood at -$1.0 in 2022, then surged by 229400.0% to $2293.0 in 2023, then rose by 11.6% to $2559.0 in 2024, then grew by 24.31% to $3181.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Tax Provisions are $3181.0 (Q4 2025), $3182.0 (Q3 2025), and $28984.0 (Q2 2025).